Jade Biosciences, Inc.

JBIO· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$16.94-1.17%

2026-09-18

Financials

Valuation Metrics

Jade Biosciences, Inc.'s Market Cap is $1.08B. At end of 2025 it was $1.09B. Ranked #2431 of 3,121 in US market (top 78%), #988 of 1,463 on NASDAQ (top 68%), #183 of 266 in Pharmaceuticals, Biotechnology & Life Sciences (top 69%) by Market Cap.

Investment Metrics(as of 2026-09-18)

Metric	Value	Rank
Size
Market Cap	$1.08B	US#2,431/3,121 Sec#183/266
Revenue	$0.00	US#2,889/3,121 Sec#196/266
Net Income	$-153M	US—/3,121 Sec—/266
Total Assets	$472M	US#2,792/3,121 Sec#171/266
Net Assets	$440M	US#2,318/3,121 Sec#122/266
Value
P/B	2.45x	US#1,528/3,121 Sec#70/266
FCF Yield	-11.47%	US—/3,121 Sec—/266
Profitability
ROE	-34.83%	US#2,598/3,121 Sec#122/266
ROA	-32.46%	US#2,901/3,121 Sec#163/266
Financial Health
Debt Ratio	7.32%	US#68/3,121 Sec#32/266
Total Debt	$628000.00	US#2,997/3,121 Sec#251/266
FCF	$-124M	US#2,680/3,121 Sec#161/266
Cash	$107M	US#2,192/3,121 Sec#170/266
Current Ratio	14.93x	US#170/3,121 Sec#51/266
Performance
1Y Return	119.71%	US#109/3,121 Sec#44/266
1M Return	-24.88%	US#3,066/3,121 Sec#260/266
From 52W High	-39.50%	US#2,429/3,121 Sec#187/266
1Y MDD	-44.21%	US#2,219/3,121 Sec#161/266
Trading
Volume	2,076,409 shares	US#1,594/3,121 Sec#174/266
Trading Value	$35M	US#2,145/3,121 Sec#172/266
Per Share
EPS	$-2.41	US—/3,121 Sec—/266
BPS	$6.92	US#2,103/3,121 Sec#101/266